Nelly Conus

This series of roundtable discussions will focus on key topics related to the challenges and opportunities faced by clinical trial sites in managing supplies. Each discussion group will provide a platform for sharing insights, discussing best practices and exploring innovative solutions aimed at optimizing the clinical trial supply chain processes.

How it Works: Choose a discussion you’d like to participate in. Each roundtable will be led by an expert facilitator. The session will consist of 40 minutes of group discussion, followed by a 20-minute feedback session

The discussion groups are:

GROUP A: Clarifying Site Roles in Clinical Trial Documentation: Defining Accountability and Responsibility

GROUP B: The Digitalization of Clinical Trial Sites: Now & Next.

GROUP C: Moving Forward: How Can Trial Sites Better Align With Supply Processes?

Decentralized clinical trials have emerged as promising approaches to accelerate drug development and reduce costs. However, the true cost-benefit analysis of these modalities remains a subject of debate. Join Nelly Conus, industry expert on change management on digital health technologies for decentralized clinical research, for this session. Nelly will delve into the economic implications of decentralized trials, exploring the potential cost savings and additional expenses associated with these approaches.

Key Discussion Points:

• Initial Investment
• Ongoing Operational Costs
• Potential Cost Savings

Recent studies indicate that 70% of clinical trial professionals report experiencing supply disruptions due to regional variability and unexpected risks, showcasing the need for robust risk management strategies. Effective planning and execution are essential to avoid delays and protect the integrity of trials. Managing global clinical trial supplies involves navigating a complex web of challenges. These include region-specific regulatory requirements, geopolitical risks, logistical obstacles, and supply chain vulnerabilities. The rise of decentralized trials and the integration of personalized therapies add further intricacies. This panel will explore how organizations can proactively identify and mitigate risks to ensure a seamless supply process for trials spanning multiple regions.

Key Topics to be Addressed:

• Risk Identification and Mitigation Frameworks: Best practices for identifying and addressing potential disruptions before they escalate.
• Navigating Regional Regulatory Challenges: Strategies to streamline compliance across diverse regulatory landscapes.
• Contingency Planning for Crisis Scenarios: Preparing for geopolitical, logistical, and natural disaster-related disruptions